HOME Top Market Reports Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021

Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021

By: marketsandmarkets.com
Publishing Date: May 2016
Report Code: MD 4294

Discount on Reports  

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021. The major drivers for the varicose vein treatment market in North America and Europe include availability of advanced varicose vein treatment devices, huge burden of varicose vein cases in North America and Europe, improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population. However, dearth of trained vascular surgeons and high cost of varicose vein treatment procedures can hinder the growth of this market. Moreover, inconsistent reimbursement scenario limiting the adoption of endovenous ablation procedures and sustainability of players in highly competitive market are further hampering the growth of this market to a certain extent.

Shift towards less-invasive treatment procedures due to the growing awareness about safety and efficacy of available treatments is the major trend in the varicose vein treatment market. In the last five years, there is a significant increase in the preference for minimally invasive and non-invasive procedures (over surgical procedures) for the treatment of varicose veins. This shift can majorly be attributed to the advantages offered by minimally invasive/non-surgical procedures, including lesser post-operative complications, less pain, and shorter recovery period. The growing trend to follow safer, efficient, and less-invasive surgical procedures is also fuelling the demand for varicose vein treatment products in North America and Europe.

Additionally, with the growing prevalence of varicose veins in North America and Europe, the demand for technologically advanced treatment methods, such as endovenous ablation, is expected to increase in these markets in the coming years. For instance, as of July 2013, around 35% of the U.K. population was affected by varicose veins. The NICE (National Institute for Health and Care Excellence in U.K.) has laid a major emphasis on the use of endothermal ablation over surgical procedures for the treatment of varicose veins (Source: NICE). Similarly, the number of varicose vein treatment procedures in North America increased to 224,000 in 2013 from 146,000 in 2012 (Source: American Society for Dermatologic Surgery).

This report broadly segments the varicose vein treatment market into mode of treatment and products. On the basis of mode of treatment, the varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. The endovenous ablation segment is expected to command the major share of the varicose vein treatment market, by mode of treatment, in 2016.

Based on type of products, the varicose vein treatment market is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices. In 2016, the radiofrequency ablation devices segment is expected to command the major share of the ablation devices market for varicose vein treatment.

Geographically, the report covers two major geographies, namely, North America and Europe. In 2016, North America is expected to command the largest share of the varicose vein treatment market in North America and Europe. However, Europe is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to increasing adoption of advanced treatment procedures and favorable government initiatives in this region.

The major players in the varicose vein treatment market are Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.), among others

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This report categorizes the varicose vein treatment market into the following segments:

Varicose Vein Treatment Market in North America and Europe, by Mode of Treatment

  • Endovenous Ablation
  • Injection Sclerotherapy
  • Surgical Ligation/Stripping

Varicose Vein Treatment Market in North America and Europe, by Product

  • Ablation Devices
    • Radiofrequency Ablation
    • Laser Ablation
  • Venous Closure Products
  • Surgical Products

Varicose Vein Treatment Market, by Region

  • North America
  • Europe
  • Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs. The following customization options are available for the report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolio of each company

Geographic Analysis

  • Further breakdown of the varicose vein treatment market into Asia-Pacific, Latin America, Middle East, and African region

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1. Introduction
     1.1 Objectives of the Study
     1.2 Market Definition
     1.3 Market Scope
            1.3.1 Markets Covered
            1.3.2 Geographic Scope
            1.3.3 Years Considered for the Study

2.Research Methodology
     2.1 Research Data
            2.1.1 Secondary Data
            2.1.2 Primary Data
     2.2 Market Size Estimation Models
     2.3 Market Size Estimation Steps
     2.4 Market Breakdown and Data Triangulation
     2.5 Research Assumptions

3. Executive Summary
     3.1 Introduction
     3.2 Snapshot of Market in North America and Europe

4. Market Dynamics
     4.1 Market Segmentation
     4.2 Overview
     4.3 Key Market Drivers
     4.4 Key Market Restraints
     4.5 Key Market Opportunities
     4.6 Key Market Challenges

5. Varicose Vein Treatment Market in North America and Europe, By Treatment Mode
     5.1 Introduction
     5.2 Endovenous Ablation
     5.3 Injection Sclerotherapy
     5.4 Surgical Ligation/Stripping

6. Varicose Vein Treatment Market in North America and Europe, By Product
     6.1 Introduction
     6.2 Ablation Devices
            6.2.1 Radiofrequency Ablation Devices
            6.2.2 Laser Ablation Devices
     6.3 Venous Closure Products
     6.4 Surgical Products

7. Varicose Vein Treatment Market, By Region
     7.1 Introduction
     7.2 North America
            7.2.1 U.S.
            7.2.2 Canada
     7.3 Europe
            7.3.1 Germany
            7.3.2 France
            7.3.3 U.K.
            7.3.4 Italy
            7.3.5 Spain
            7.3.6 Rest of Europe (RoE)

8. Competitive Landscape
     8.1 Introduction
     8.2 Market Share Analysis
     8.3 Competitive Scenario
     8.4 Recent Developments
            8.4.1 New Product Launches
            8.4.2 Acquisitions
            8.4.3 Agreements
            8.4.4 Other Developments

9. Company Profiles
     9.1 Introduction
            9.1.1 Geographic Benchmarking
     9.2 Angiodynamics, Inc. (U.S.)
     9.3 Medtronic, PLC (U.S.)
     9.4 Biolitec Ag (Austria)
     9.5 Syneron Medical Ltd. (Israel)
     9.6 Lumenis Ltd. (Israel)

10. Appendix
      10.1 Discussion Guide
      10.2 Introducing RT: Real-Time Market Intelligence
      10.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
      10.4 Available Customizations
      10.5 Related Reports
 

List of Tables (67 Tables)

Table - 1 Prevalence of Varicose Veins in the European Region
Table – 2 Prevalence of Primary Varicose Veins in European Region (2013) (Thousand)
Table – 3 Reimbursement Scenario for Varicose Vein Treatments in Europe, By Country
Table – 4 Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 5 Varicose Vein Treatment Modes Market Size, By Region, 2014–2021 (USD Million)
Table – 6 Varicose Vein Treatment Modes Market Size (USD Million) and Market Share (%), By Country, 2016
Table – 7 North America: Varicose Vein Treatment Modes Market Size, By Country, 2014–2021 (USD Million)
Table – 8 Europe: Varicose Vein Treatment Modes Market Size, By Country, 2014–2021 (USD Million)
Table – 9 Endovenous Ablation Market Size, By Region, 2014–2021 (USD Million)
Table – 10 North America: Endovenous Ablation Market Size, By Country, 2014–2021 (USD Million)
Table – 11 Europe: Endovenous Ablation Market Size, By Country, 2014–2021 (USD Million)
Table – 12 Injection Sclerotherapy Market Size, By Region, 2014–2021 (USD Million)
Table – 13 North America: Injection Sclerotherapy Market Size, By Country, 2014–2021 (USD Million)
Table – 14 Europe: Injection Sclerotherapy Market Size, By Country, 2014–2021 (USD Million)
Table – 15 Surgical Ligation/Stripping Market Size, By Region, 2014–2021 (USD Million)
Table – 16 North America: Surgical Ligation/Stripping Market Size, By Country, 2014–2021 (USD Million)
Table – 17 Europe: Surgical Ligation/Stripping Market Size, By Country, 2014–2021 (USD Million)
Table – 18 Market Size, By Product, 2014–2021 (USD Million)
Table – 19 Varicose Vein Treatment Product Market Size, By Region, 2014–2021 (USD Million)
Table – 20 North America: Varicose Vein Treatment Product Market Size, By Country, 2014–2021 (USD Million)
Table – 21 Europe: Varicose Vein Treatment Product Market Size, By Country, 2014–2021 (USD Million)
Table – 22 Varicose Vein Treatment Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table – 23 Ablation Devices Market Size, By Region, 2014–2021 (USD Million)
Table – 24 North America: Ablation Devices Market Size, By Country, 2014–2021 (USD Million)
Table – 25 Europe: Ablation Devices Market Size, By Country, 2014–2021 (USD Million)
Table – 26 Radiofrequency Ablation Devices Market Size, By Region, 2014–2021 (USD Million)
Table – 27 North America: Radiofrequency Ablation Devices Market Size, By Country 2014–2021 (USD Million)
Table – 28 Laser Ablation Devices Market Size, By Region, 2014–2021 (USD Million)
Table – 29 North American Venous Closure Products Market Size, By Country, 2014–2021 (USD Million)
Table – 30 North America: Laser Ablation Devices Market Size, By Country 2014–2021 (USD Million)
Table – 31 Europe: Laser Ablation Devices Market Size, By Country, 2014–2021 (USD Million)
Table – 32 Venous Closure Products Market Size, By Region, 2014–2021 (USD Million)
Table – 33 North America: Venous Closure Products Market Size, By Country, 2014–2021 (USD Million)
Table – 34 Europe: Venous Closure Products Market Size, By Country, 2014–2021 (USD Million)
Table – 35 Surgical Products Market Size, By Region, 2014–2021 (USD Million)
Table – 36 North America: Surgical Products Market Size, By Country, 2014–2021 (USD Million)
Table – 37 Europe: Surgical Products Market Size, By Country, 2014–2021 (USD Million)
Table – 38 Market Size, By Region, 2014-2021 (USD Million)
Table – 39 Market Size, By Country 2014-2021 (USD Million)
Table – 40 North America: Market Size, By Country and Treatment Mode, 2016 (USD Million)
Table – 41 North America: Market Size, By Country, 2014-2021 (USD Million)
Table – 42 North America: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table – 43 North America: Market Size, By Product, 2014-2021 (USD Million)
Table – 44 U.S.: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table – 45 U.S.: Market Size, By Product, 2014-2021 (USD Million)
Table – 46 Canada: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table – 47 Canada: Market Size, By Product, 2014-2021 (USD Million)
Table – 48 Europe: Market Size, By Country and Treatment Mode, 2016 (USD Million)
Table – 49 Europe: Market Size, By Country, 2014-2021 (USD Million)
Table – 50 Europe: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table – 51 Europe: Market Size, By Product, 2014-2021 (USD Million)
Table – 52 Germany: Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 53 Germany: Market Size, By Product, 2014–2021 (USD Million)
Table – 54 France: Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 55 France: Market Size, By Product, 2014–2021 (USD Million)
Table – 56 U.K.: Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 57 U.K.: Market Size, By Product, 2014–2021 (USD Million)
Table – 58 Italy: Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 59 Italy: Market Size, By Product, 2014–2021 (USD Million)
Table – 60 Spain: Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 61 Spain: Market Size, By Product, 2014–2021 (USD Million)
Table – 62 Rest of Europe: Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 63 Rest of Europe: Market Size, By Product, 2014–2021 (USD Million)
Table – 64 New Product Launches (2013–2016) (CNTD…)
Table – 65 Acquisitions (2013-2016)
Table – 66 Agreements (2013-2016)
Table – 67 Other Developments (2013-2016)


List of Figures (19 Figures)

Figure-1 Research Design
Figure-2 Breakdown of Primary Interviews: By Company Type, Designation, & Country
Figure-3 North American Varicose Vein Treatment Market, By Country: Market Share (2016) and CAGR (2016–2021)
Figure-4 European Market, By Country: Market Share (2016) and CAGR (2016–2021)
Figure-5 Healthcare Expenditures as Percentage of GDP in Major European Countries
Figure-6 Key Markets: Changing Proportion of Geriatric Individuals (Aged 65 Years and Above) in Total Population (2020 vs. 2030)
Figure-7 Market Share, By Product (2016–2021) (USD Million)
Figure-8 North America: Market, By Mode of Treatment, 2016 (%)
Figure-9 North America: Market Share, By Country (2016 vs. 2021)
Figure-10 North America: Market Share, By Mode of Treatment, 2016
Figure-11 Europe: Market, By Mode of Treatment, 2016 (USD Million)
Figure-12 Europe: Market Share, By Country (2016 vs. 2021)
Figure-13 EU-5: Market Share, By Mode of Treatment, 2016
Figure-14 Leading Market Players Adopted Product Development and Commercialization as Key Growth Strategies During 2012-2015
Figure-15 Market Share, By Key Player (2015)
Figure-16 Product Development, the Most Widely Adopted Growth Strategy During 2013-2016
Figure-17 Geographic Benchmarking
Figure-18 Marketsandmarkets Knowledge Store Snapshot
Figure-19 Marketsandmarkets Knowledge Store: Healthcare Industry Snapshot 

The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021. Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, and huge burden of varicose vein cases in North America and Europe is driving the growth of the market. Other growth factors include improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.

However, dearth of training for vascular surgeons, high cost of varicose vein treatment procedures, and implementation of healthcare reforms in the U.S. are some of the key factors restraining the growth of this market. In addition to this, challenges associated with inconsistent reimbursement scenario for varicose vein treatment procedures and sustainability of players in the highly competitive market also limits the growth of the market.

This report broadly segments the varicose vein treatment market into mode of treatment and products. On the basis of mode of treatment, the market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. The endovenous ablation segment is expected to command the major share of the market, by mode of treatment, in 2016.

Based on type of products, the varicose vein treatment market is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices. In 2016, the radiofrequency ablation devices segment is expected to command the major share of the ablation devices market for varicose vein treatment.

This report covers the varicose vein treatment market across two major geographies, namely, North America and Europe. In this report, the North American market is further segmented into the U.S. and Canada, while the European varicose vein treatment market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe. In 2016, North America is expected to command the largest share of the market in North America and Europe. However, Europe is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to increasing adoption of advanced treatment procedures and favorable government initiatives in this region.

Major players in the varicose vein treatment market include Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.), among others

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Minimally Invasive/Non-Invasive Surgery Markets on KnowledgeStore
Request Demo